Nov 27, 2023 at 5:30 AM#1
Nobody talks about the supplies, so I'm going to. GGPeps sells reconstitution kits and individual supplies alongside their peptides. I've been buying everything from them as a one-stop-shop for 5 months. Here's my review of each item:
Bacteriostatic Water (BAC Water) — 30ml vial — $8
- Clear, properly sealed with rubber stopper and flip-top
- Label shows 0.9% benzyl alcohol (industry standard preservative concentration)
- Expiration date printed (mine shows 18 months out)
- No particulates visible when held up to light
- Rating: 8/10 — does its job, reasonably priced. You can find it cheaper on Amazon but the convenience of adding it to your peptide order is nice.
Insulin Syringes — 29g 1/2" 1ml — 100 count — $12
- Standard quality, comparable to BD brand
- Markings are clear and easy to read
- Needles are sharp (no painful pokes or bent tips)
- Individually wrapped in sterile packaging
- Rating: 7/10 — perfectly functional but slightly pricier than buying from a medical supplier. 100 syringes for $12 vs $8 on Amazon for the same count.
Alcohol Prep Pads — 200 count — $6
- Standard 70% isopropyl alcohol pads
- Good saturation, not dried out
- Individually foil-wrapped
- Rating: 6/10 — these are literally the same as any pharmacy brand. You're paying $3-4 more than you would at CVS. Only buy these for convenience.
Reconstitution Kit (Bundle) — $22
Contains: 1x BAC water 30ml, 50x syringes, 100x alcohol pads, 1x mixing syringe (18g for drawing BAC water)
- Rating: 8/10 — good starter kit. The mixing syringe inclusion is smart — drawing BAC water through a 29g insulin needle is painful and slow. The 18g makes it quick.
Overall supplies verdict: GGPeps supplies are perfectly adequate. You pay a slight premium for the convenience of one-stop shopping. If you're cost-conscious, buy your supplies from Amazon/medical suppliers and only get peptides from GGPeps. If you value simplicity, the bundle is a solid deal for getting started. 🧪
12 15wei_SG, cory_ATX, lori_vegas and 9 others
Reply Quote Save Share Report